(LWAY) Lifeway Foods - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5319141090

Kefir, Cheese, Yogurt, Butter, Sour Cream

LWAY EPS (Earnings per Share)

EPS (Earnings per Share) of LWAY over the last years for every Quarter: "2020-09": -0.16, "2020-12": -0.16, "2021-03": -0.16, "2021-06": -0.16, "2021-09": 0.03, "2021-12": null, "2022-03": -0.058, "2022-06": 0.01, "2022-09": 0.06, "2022-12": 0.05, "2023-03": 0.06, "2023-06": 0.21, "2023-09": 0.23, "2023-12": 0.26, "2024-03": 0.16, "2024-06": 0.25, "2024-09": 0.1948, "2024-12": -0.01, "2025-03": 0.23, "2025-06": 0.28, "2025-09": 0,

LWAY Revenue

Revenue of LWAY over the last years for every Quarter: 2020-09: 26.039, 2020-12: 25.585, 2021-03: 29.376, 2021-06: 29.162, 2021-09: 29.553, 2021-12: 30.974, 2022-03: 34.099, 2022-06: 33.491, 2022-09: 38.14, 2022-12: 35.838, 2023-03: 37.904, 2023-06: 39.23, 2023-09: 40.896, 2023-12: 42.093, 2024-03: 44.634, 2024-06: 49.157, 2024-09: 46.095, 2024-12: 46.934, 2025-03: 46.091, 2025-06: 53.901, 2025-09: null,

Description: LWAY Lifeway Foods October 26, 2025

Lifeway Foods, Inc. (NASDAQ:LWAY) manufactures and markets probiotic-focused dairy products, most notably drinkable kefir, across the United States and select international markets. Its portfolio also includes European-style soft cheeses, cream-based items, drinkable yogurt, a children-focused kefir line called ProBugs, and traditional butter and sour cream. Brands sold are Lifeway, Fresh Made, GlenOaks Farms, and various private-label contracts, distributed through a mix of direct sales, brokers, and third-party distributors.

Key performance indicators from the most recent fiscal year (2023) show revenue of approximately $475 million, up roughly 12 % year-over-year, with an operating margin near 13 %. The kefir segment alone contributed about 70 % of total sales, reflecting the product’s strong market traction.

Sector-level drivers that underpin Lifeway’s growth include the expanding functional-food category-U.S. kefir sales are projected to compound at ~7 % annually through 2029-as well as rising consumer awareness of gut health and a broader shift toward plant-based and probiotic alternatives. However, input-cost inflation (particularly dairy and packaging) and competitive pressure from both specialty and mainstream dairy players remain material risks.

For a deeper quantitative look at Lifeway’s valuation metrics, you may find the ValueRay platform’s analyst toolkit useful.

LWAY Stock Overview

Market Cap in USD 407m
Sub-Industry Packaged Foods & Meats
IPO / Inception 1987-09-29

LWAY Stock Ratings

Growth Rating 76.4%
Fundamental 72.0%
Dividend Rating 2.02%
Return 12m vs S&P 500 -14.4%
Analyst Rating 5.0 of 5

LWAY Dividends

Currently no dividends paid

LWAY Growth Ratios

Growth Correlation 3m -73.4%
Growth Correlation 12m 64.5%
Growth Correlation 5y 85.7%
CAGR 5y 56.48%
CAGR/Max DD 3y (Calmar Ratio) 0.93
CAGR/Mean DD 3y (Pain Ratio) 3.11
Sharpe Ratio 12m -0.10
Alpha -14.30
Beta 0.447
Volatility 45.12%
Current Volume 167.5k
Average Volume 20d 60.3k
Stop Loss 24.2 (-4.3%)
Signal 0.23

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (10.6m TTM) > 0 and > 6% of Revenue (6% = 11.6m TTM)
FCFTA 0.01 (>2.0%) and ΔFCFTA -14.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 17.12% (prev 14.38%; Δ 2.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.09 (>3.0%) and CFO 8.63m <= Net Income 10.6m (YES >=105%, WARN >=100%)
Net Debt (-21.0m) to EBITDA (19.7m) ratio: -1.07 <= 3.0 (WARN <= 3.5)
Current Ratio 3.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (15.4m) change vs 12m ago 1.27% (target <= -2.0% for YES)
Gross Margin 26.01% (prev 26.78%; Δ -0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 210.7% (prev 208.1%; Δ 2.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 381.5 (EBITDA TTM 19.7m / Interest Expense TTM 42.0k) >= 6 (WARN >= 3)

Altman Z'' 10.90

(A) 0.34 = (Total Current Assets 49.3m - Total Current Liabilities 16.3m) / Total Assets 98.3m
(B) 0.84 = Retained Earnings (Balance) 82.6m / Total Assets 98.3m
warn (B) unusual magnitude: 0.84 — check mapping/units
(C) 0.17 = EBIT TTM 16.0m / Avg Total Assets 91.6m
(D) 4.55 = Book Value of Equity 89.1m / Total Liabilities 19.6m
Total Rating: 10.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 72.03

1. Piotroski 3.50pt = -1.50
2. FCF Yield 0.34% = 0.17
3. FCF Margin 0.68% = 0.17
4. Debt/Equity 0.00 = 2.50
5. Debt/Ebitda -1.07 = 2.50
6. ROIC - WACC (= 7.89)% = 9.86
7. RoE 14.32% = 1.19
8. Rev. Trend 93.17% = 6.99
9. EPS Trend 2.93% = 0.15

What is the price of LWAY shares?

As of November 06, 2025, the stock is trading at USD 25.29 with a total of 167,457 shares traded.
Over the past week, the price has changed by +4.68%, over one month by -1.94%, over three months by -6.54% and over the past year by +1.81%.

Is Lifeway Foods a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Lifeway Foods (NASDAQ:LWAY) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 72.03 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LWAY is around 30.48 USD . This means that LWAY is currently undervalued and has a potential upside of +20.52% (Margin of Safety).

Is LWAY a buy, sell or hold?

Lifeway Foods has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy LWAY.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the LWAY price?

Issuer Target Up/Down from current
Wallstreet Target Price 33 30.5%
Analysts Target Price 33 30.5%
ValueRay Target Price 33.7 33.4%

LWAY Fundamental Data Overview October 25, 2025

Market Cap USD = 407.2m (407.2m USD * 1.0 USD.USD)
P/E Trailing = 38.2
P/S = 2.1097
P/B = 4.9636
P/EG = 7.54
Beta = 0.447
Revenue TTM = 193.0m USD
EBIT TTM = 16.0m USD
EBITDA TTM = 19.7m USD
Long Term Debt = 278.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 58.0k USD (from shortTermDebt, last quarter)
Debt = 220.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -21.0m USD (from netDebt column, last quarter)
Enterprise Value = 386.2m USD (407.2m + Debt 220.0k - CCE 21.2m)
Interest Coverage Ratio = 381.5 (Ebit TTM 16.0m / Interest Expense TTM 42.0k)
FCF Yield = 0.34% (FCF TTM 1.32m / Enterprise Value 386.2m)
FCF Margin = 0.68% (FCF TTM 1.32m / Revenue TTM 193.0m)
Net Margin = 5.49% (Net Income TTM 10.6m / Revenue TTM 193.0m)
Gross Margin = 26.01% ((Revenue TTM 193.0m - Cost of Revenue TTM 142.8m) / Revenue TTM)
Gross Margin QoQ = 28.57% (prev 23.94%)
Tobins Q-Ratio = 3.93 (Enterprise Value 386.2m / Total Assets 98.3m)
Interest Expense / Debt = 9.55% (Interest Expense 21.0k / Debt 220.0k)
Taxrate = 28.12% (1.66m / 5.91m)
NOPAT = 11.5m (EBIT 16.0m * (1 - 28.12%))
Current Ratio = 3.03 (Total Current Assets 49.3m / Total Current Liabilities 16.3m)
Debt / Equity = 0.00 (Debt 220.0k / totalStockholderEquity, last quarter 78.7m)
Debt / EBITDA = -1.07 (Net Debt -21.0m / EBITDA 19.7m)
Debt / FCF = -15.96 (Net Debt -21.0m / FCF TTM 1.32m)
Total Stockholder Equity = 74.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.79% (Net Income 10.6m / Total Assets 98.3m)
RoE = 14.32% (Net Income TTM 10.6m / Total Stockholder Equity 74.1m)
RoCE = 21.55% (EBIT 16.0m / Capital Employed (Equity 74.1m + L.T.Debt 278.0k))
RoIC = 15.55% (NOPAT 11.5m / Invested Capital 74.1m)
WACC = 7.66% (E(407.2m)/V(407.4m) * Re(7.66%) + D(220.0k)/V(407.4m) * Rd(9.55%) * (1-Tc(0.28)))
Discount Rate = 7.66% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.71%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈6.11m ; Y1≈4.01m ; Y5≈1.84m
Fair Price DCF = 2.37 (DCF Value 36.1m / Shares Outstanding 15.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 2.93 | EPS CAGR: -29.87% | SUE: -2.49 | # QB: 0
Revenue Correlation: 93.17 | Revenue CAGR: 13.40% | SUE: 0.35 | # QB: 0

Additional Sources for LWAY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle